We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

West Pharmaceutical Services Inc (WST) USD0.25

Sell:$332.16 Buy:$332.67 Change: $3.20 (0.97%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$332.16
Buy:$332.67
Change: $3.20 (0.97%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$332.16
Buy:$332.67
Change: $3.20 (0.97%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Contact details

Address:
530 Herman O. West Drive
EXTON
19341
United States
Telephone:
+1 (610) 5942900
Website:
https://www.westpharma.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
WST
ISIN:
US9553061055
Market cap:
$23.87 billion
Shares in issue:
72.42 million
Sector:
Life Sciences Tools & Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Eric Green
    Chairman of the Board, President, Chief Executive Officer
  • Bernard Birkett
    Chief Financial Officer
  • Annette Favorite
    Chief Human Resource Officer, Senior Vice President
  • Silji Abraham
    Senior Vice President, Chief Technology Officer
  • Kimberly Mackay
    Senior Vice President, General Counsel, Corporate Secretary
  • Cindy Reiss-Clark
    Senior Vice President - Global Markets and Commercial Solutions, Chief Commercial Officer
  • Chad Winters
    Chief Accounting Officer, Vice President, Corporate Controller
  • Quintin Lai
    Vice President - Strategy and Investor Relations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.